ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Critical Care Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,415Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 101

$505K Total Retail Price of All Prescriptions

Rank: 6 out of 101

166 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 3,531 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 57%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $167 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
IPRATROPIUM-ALBUTEROL 291 209 1 33
IPRATROPIUM BROMIDE 290 150 2 30
PREDNISONE 243 194 3 5
FAMOTIDINE 229 126 4 31
ADVAIR DISKUS 217 196 5 2
SPIRIVA 203 129 6 1
TRIAMCINOLONE ACETONIDE 140 58 7 49
FUROSEMIDE 133 92 8 7
ACETYLCYSTEINE 118 80 10 9 89
PROAIR HFA 109 78 10 3
LEVETIRACETAM 100 54 11 43
POTASSIUM CHLORIDE 89 55 12 23
METFORMIN HCL 88 50 13 15
VALPROIC ACID 83 29 14 104
NYSTATIN 83 27 14 104
METOCLOPRAMIDE HCL 79 40 16 76
CEFTAZIDIME 78 53 10 17 108
LEVOTHYROXINE SODIUM 78 48 17 13
CLOTRIMAZOLE 76 28 19 70
NOVOLIN N 66 37 20 87
NOVOLIN R 61 46 21 128
FLOVENT HFA 59 35 22 92
ALBUTEROL SULFATE 58 32 23 72
E.E.S. 200 56 56 24 133
SYMBICORT 55 54 25 18
DIGOXIN 50 50 26 47
SERTRALINE HCL 50 34 26 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.